Sage Therapeutics to cut 40% of jobs after depression drug setback ...Middle East

Bloomberg News Today - News
Sage Therapeutics to cut 40% of jobs after depression drug setback
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights Aug 31 (Reuters) – Sage Therapeutics (SAGE.O) said on Thursday it would cut its workforce by about 40%, weeks after the U.S. health regulator declined to approve its drug to treat major depressive disorder. The U.S. Food and Drug Administration (FDA) in early August approved the company and partner Biogen’s (BIIB.O) pill for postpartum depression, but rejected it as a treatment for major depressive disorder, which is a much larger market. Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi M

Read More Details
Finally We wish PressBee provided you with enough information of ( Sage Therapeutics to cut 40% of jobs after depression drug setback )

Also on site :